Brind.

Greg Mueller joined Genmab as Executive Vice President, moving from AstraZeneca.

1 report, 0 independent Updated Jul 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Genmab AstraZeneca

Keep exploring

The entities involved

Genmab
Danish healthcare company
- Genmab, a Danish biotechnology company, granted stock units and warrants via its Board of Directors on September 1, 2026.Thu 21:07
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52

Coverage

Newest first; wire copies grouped

Jul 1Unknown outlet